S. Fukada et al., STEROIDOGENESIS IN THE OVARIAN FOLLICLE OF MEDAKA (ORYZIAS-LATIPES, ADAILY SPAWNER) DURING OOCYTE MATURATION, Development, growth & differentiation, 36(1), 1994, pp. 81-88
The metabolism of C-14-labeled steroid precursors by cell-free homogen
ates of medaka (Oryzias latipes, a daily spawner) ovarian follicles at
12 different developmental stages was examined using thin layer chrom
atography (TLC). The radioactive metabolites produced were identified
and tested for their ability to induce germinal vesicle breakdown (GVB
D) in oocytes in an in vitro homologous bioassay. When homogenates of
follicles isolated during oocyte maturation were incubated with C-14-l
abeled 17 alpha-hydroxyprogesterone roxyprogesterone, 13 metabolites w
ere detected in TLC. Among these metabolites, one metabolite exhibited
very high maturation inducing activity by the in vitro bioassay. This
metabolite was identified as 17 alpha,20 beta-dihydroxy-4-pregnen-3-o
ne (17 alpha,20 beta-DP) by its chromatographic mobility in TLC and re
crystallization to constant specific activity. 17 alpha,20 beta-DP pro
duction was high in follicles collected between 10 and 6 hr before spa
wning. A much less biologically active metabolite, 17 alpha,20 beta-di
hydroxy-5 beta-pregnane-3-one appeared in follicles immediately after
the formation of 17 alpha,20 beta-DP. A similar pattern of steroidogen
esis was observed when the follicles were incubated with C-14-labeled
pregnenolone and progesterone. The timely synthesis of 17 alpha,20 bet
a-DP in medaka at the onset of oocyte maturation, together with the de
monstration that this progestogen is the most potent inducer of oocyte
maturation in vitro, provides further evidence that 17 alpha,20 beta-
DP is the naturally occurring maturation-inducing hormone in the medak
a. The results also suggest that the conversion of 17 alpha,20 beta-DP
to its SP-reduced metabolite may be an inactivation process.